James Frith MP: speeches

Speeches

• 10 Sept 2026 · Vascular Sector Reform · Hansard source

  More

  It is a genuine pleasure to serve under your chairship, Dr Huq, and to join you again in Parliament. We worked together before and it is an honour to be here today. As is customary, I would like to thank the hon. Member for Strangford (Jim Shannon) for securing this important debate and for his insights. Some of us were wondering if he would write one of his famous letters of congratulations and courtesy to himself; we hope that somebody else will step up and show him the same courtesy that he affords us all by being so generous in his support of colleagues across the House. I also thank my hon. Friend the Member for Glasgow South West (Dr Ahmed), who spoke so well and with such insight, for the leadership and expertise that he showed in pulling together the Government’s ambitions for not just the 10-year plan but, as has been mentioned, the cardiovascular framework. I am of course minded to listen to anything further that he says. On his point about Scotland, he is right that I also have responsibility for the devolved nations in a seemingly ever-growing brief—he will have sympathy with me over that. I am happy to have those conversations to ensure that we learn from the Scots and that the successes here can be transported north of the non-border to which he rightly referred. The report published by the APPG earlier this year sets out suggested actions for improving vascular care. The Opposition spokesperson, the hon. Member for Solihull West and Shirley (Dr Shastri-Hurst), is right that there is much in this debate on which we agree. The calls to action include reducing waiting times, reforming commissioning, accelerating innovation, and establishing a national foot care pathway and community-based foot protection services in every local system. I commend the APPG for focusing their challenges on structural reforms and system changes, and not on simply making a new request for funding. We can all agree with the improvements the actions intend to deliver, which are, “earlier diagnosis, reduced travel and access barriers for patients, and relieving pressure on acute services by preventing deterioration and avoidable hospital admissions.” That is crucial. At the election, I was pleased to stand for a party that wanted, when in government, to bring its power and might to bear on the biggest killers. The Government very much intend to deliver those improvements through the core shifts set out in the 10-year plan for the NHS. For patients with vascular disease, that will mean fewer trips to hospital as we shift care closer to home and into the community. It will mean better use of digital technology—my hon. Friend the Member for Glasgow South West referred to the innovation part of my title, and there is more to come on that—to identify vascular disease, monitor its progression and, finally, stop it from developing or worsening. In preparation for this debate, I have been encouraged—mercifully, I am pleased to say—to use my remarks reflect the call to action from the APPG.

• 10 Sept 2026 · Vascular Sector Reform · Hansard source

  More

  I hope that my further remarks will address that very point; I am happy to pick it up with the hon. Member in due course if they do not satisfy. ICBs will use national modern service frameworks set by the Government and guidance to create the right services for their areas. That means local systems coming together to create neighbourhood services that reform the health and care system and are rooted in the needs of people and communities. On the issue of maximum waiting times for vascular disease, this Government recognise that it is imperative that any patient requiring a vascular assessment receives that in a timeframe that reflects their condition and enables the best possible health outcome. The Government are committed to making progress on NHS waiting times, including returning by March ’29 to the NHS constitutional standard of 92% of elective care patients’ waiting times from referral to treatment being within 18 weeks. Of course, that includes those patients waiting for vascular services. The NHS met the first interim target of 65% in March ’26, and we are now focused on driving improvements to achieve our second interim target of 70% by 2027. To help support the commitment to reduce waiting times, the podiatry workforce pipeline is currently being strengthened through NHS England’s focus programme for small and vulnerable professions, with the NHS workforce plan to be published shortly. The health service also has clear guidance on what is required in delivering services for people with vascular disease or at risk of developing it. In March ’26, NHS England published guidance on standardising community health services. That guidance identifies podiatry, diabetes and tissue viability, and wound care as core components of ICB-funded community provision. People who need urgent wound assessment—for example, those with suspected infection, rapid deterioration, or diabetic foot ulcer—should be seen within 24 hours. The guidance also makes it clear that routine assessments should occur within five to seven working days, with data collected on healing and complications. The purpose and goal of community health services must be to support people as well as to avoid their needing to be admitted to hospital and, critically, the need for amputations.

• 10 Sept 2026 · Vascular Sector Reform · Hansard source

  More

  The hon. Member is absolutely right. We have to keep ICBs and their commissioning powers accountable to local jurisdictions. I will say a bit more on that in due course, but we are on the same page. To facilitate faster assessments we also need to speed up and make earlier diagnoses, which is why the Government plan to open four new community diagnostic centres during ’26-27. That expanding capacity will help meet our March ’29 target that no more than 1% of patients should wait over six weeks for a diagnostic test. On reforming commissioning to reward outcomes, as set out in the 10-year health plan, we want to develop new ways to pay healthcare providers based on clinical practice that maximises productivity and outcome, as my hon. Friend the Member for Glasgow South West mentioned. Under the best practice tariffs, providers receive payment when they follow agreed standards of care. On the adoption of proven innovation, the APPG report rightly identifies the importance of the NHS being able to quickly adopt new innovations. As part of my responsibility to oversee further development and enhancement of the use and usability of the NHS app, one development coming through the House at the moment is the creation of the single patient record. The future exciting development of NHS online, or digital doctor, as I might yet call it, is about the digitisation of our NHS service—embracing innovation, personalising healthcare and responsive to individual need—as well as the innovator passport, delivered through a phased approach to accelerate access to and adoption of technologies. The APPG’s report says that preventing vascular disease and its deterioration should be at the centre of the system, and I agree. Identifying people with vascular diseases and providing care centred on their needs is critical to ensuring vascular disease does not progress to the point where somebody needs incredibly serious interventions, such as a leg needing to be amputated. In this modern era, such amputations are wholly avoidable and should be prevented. The distinction between the APPG’s report and the Government’s most recent announcement of the MSF has been mentioned. I was delighted to join the British Heart Foundation yesterday at the celebration event for the MSF ahead of the delivery plan later in the year. It is a reasonable challenge to ensure that we distinguish between conditions, a point made by the Opposition spokesperson, the hon. Member for Solihull West and Shirley. It was a point made to me—and a point I thought was likely to be raised with me—by stroke and diabetes charities at the event yesterday. We are on the same page on that. He made an excellent point and challenge on the distinction that is needed. As hon. Members will know, prevention is at the heart of the Government’s health agenda—the prevention of health conditions and the prevention of them worsening. The cardiovascular disease modern service framework, which was published in July, sets a clear direction for how health and care systems should accelerate progress on the Government’s ambition to reduce premature mortality from heart disease and stroke by a quarter within a decade. My hon. Friend the Member for Broxtowe (Juliet Campbell) talked about irregularity and different areas having different levels of heart failure, which she said was four times more likely in the area she represents. I would be very happy to have conversations about how we can embrace that insight and intervene. Prevention is fundamental to the Government’s efforts around an annual heart failure review, improving access to rapid diagnosis and embedding heart failure support in cardiac rehabilitation, as well as the wider Government goal to reduce premature mortality by a quarter within the next decade. Central to the cardiovascular disease modern service framework is a holistic approach with a strong focus on reducing inequalities. The principles apply here, too: the missing millions; the need for healthy intervention and to understand the difference between the physiological, behavioural, environmental and social; an appreciation that living standards and the cost of living have as much impact as any knowledge of what to eat and when; and looking after each other. It is about commissioning for outputs, not just diktat, which means recognising that several conditions and risk factors share common causes and contribute to most heart attacks and strokes. Members have described them in their speeches: high blood pressure, smoking, diabetes, high cholesterol, unhealthy diet and lack of exercise. At its core, the framework is about a fundamental shift towards proactive, whole-person, preventive care that is located in communities and neighbourhoods and makes better use of hybrid, traditional, in-person and digital models to increase uptake and treatment. Podiatry and related foot-health services align with the shift towards local community hub delivery. The framework’s approach is backed by wider Government, including the creation of the first smoke-free generation, which began under the Conservative Government.

• 1 Sept 2026 · Sudden Cardiac Death: Young People · Hansard source

  More

  I thank my hon. Friend for her intervention; I hope I will cover and do justice to those important points. NHS pathways also give providers call-level CPR data to support local reviews and improve quality, as well as reviewing data and emerging evidence to see where we must do better. They send quarterly reports to the national clinical assurance group, which is made up of senior clinicians drawn from royal colleges, professional bodies and urgent and emergency care services. These professionals can and often do submit constructive feedback on the way that pathways are run. At present, NHS clinical staff are trained in CPR, but from April 2027, this will be extended to all NHS staff, including those in A&E. The roll-out of this training will take time, but it will hugely increase the number of people in the country with valuable lifesaving knowledge. Finally, when it comes to recognising cardiac arrest, I can confirm that the Care Quality Commission does assess call handlers’ skill as part of its inspections. We know that no human system is perfect, and I am all too aware that a list or accounts like this can risk sounding defensive, so let me repeat my openness to sitting with the hon. Member for Mid Buckinghamshire, Adam’s parents and other colleagues to see how and where we can do better and go further. Turning to the hon. Member’s points about genetics, I am hugely optimistic about the potential of genomics and life sciences over the next 10 years. The NHS clinical genetics services deliver a comprehensive clinical genetics and genetic counselling service for individuals with a family history of genetic conditions, including cardiac conditions. They provide a detailed review of family history that can direct the diagnosis, risk assessment and lifelong clinical management of patients of all ages and their families who have, or are at risk of having, a genomic condition. The current specification for the clinical genetics services was published more than a decade go under the previous Government and is no longer fit for purpose, not least because this is one of the most innovative fields in healthcare. Today, specialist clinical services simply do not have the capacity or infrastructure to contact family members proactively, except where a particularly high risk has already been identified. For me and my work, it is a clear example of why innovation must help connect our public services. NHS England’s genomics programme, working with the genomics clinical reference group, has done a review of the 17 regional NHS clinical genetics services. This has shone a light on the challenges to be addressed for this service to match the Government’s expectations. I am unable to confirm a specific date for the hon. Member for Mid Buckinghamshire, but suffice to say, there is much more to be done before expectations are met by service. On his point about the UK National Screening Committee, it is true that the draft recommendations, which have been consulted on, did not find that the current scientific evidence—

• 1 Sept 2026 · Sudden Cardiac Death: Young People · Hansard source

  More

  I never fail to be impressed by the sheer determination of humans who have endured the worst of losses to turn such loss into a positive contribution. Without hesitation, I pay tribute to Mia’s family for their fundraising efforts. Done properly, innovation can support more joined-up care and personalised services, and faster sharing and implementation of new guidance and learning. Let me now turn to some of the specific points raised by the hon. Member for Mid Buckinghamshire. NHS England has made changes to the call script in response to new advice from Resuscitation Council UK, issued in November 2023. That advice was given just two months before Adam’s death. It is tragic that it had not yet come into force by the time that Adam stepped on to that pitch. As healthcare professionals, Adam’s mum and dad will know that those changes would have given him a much better chance of survival, as callers now receive advice to begin life support, as well as the certainty of using a defibrillator on a teenager. The hon. Gentleman raised a number of important points about the NHS pathways system. The challenge we face in improving the sensitivity of cardiac arrest identification is to do so in a way that does not generate false positives. Ongoing performance monitoring of NHS pathways finds that the system accepts over-triage; this is an intentional safety feature of triage systems. As the hon. Gentleman knows, at a time when many ambulance services are under such significant strain, the management of stretched resources is paramount. The hon. Gentleman is right in saying that NHS England works with the NHS pathways clinical team, ambulance services and specialist organisations, including Resuscitation Council UK, to review data and emerging evidence and to see where we can do better.